According to the 2020 edition of CSCO guidelines for breast cancer diagnosis and treatment, positive PR20% is considered as the critical value for Luminal A and Luminal B, Ki-67 < 15% was low expression, > 30% was high expression, 87 breast cancer patients were molecularly classified. This evidence concerns the gene MKI67 and breast carcinoma.